A new form of cancer treatment, Genetically Targested Fractioned Chemotherapy (GTF) is being investigated for patients with late stage complex cancers. Focusing on the premise that each patient's cancer is unique, GTF provides a unique genetic blueprint of the cancer allowing personalization of a patient's treatment plan.
Doctors believe that in 5-7 years, GTF could become a world standard of chemotherapy treatment, due to its role in "reducing the imminent damage to the immune system that is commonly the result of a more conventional administration."
To read more about GTF, click here
No comments:
Post a Comment